No Effect of Fibrates on Synthesis of Apolipoprotein(a) in Primary Cultures of Cynomolgus Monkey and Human Hepatocytes: Apolipoprotein A-I Synthesis Increased

This publication has 33 references indexed in Scilit:

• PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
  The EMBO Journal, 1996
• Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability
  The American Journal of Cardiology, 1995
• Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.
  Journal of Clinical Investigation, 1995
• The effects of fibrates on lipoprotein and hemostatic coronary risk factors
  Atherosclerosis, 1994
• Treatment of patients with familial defective apolipoprotein B-100 with pravastatin and gemfibrozil: a two-period cross-over study
  Journal of Molecular Medicine, 1994
• Role of fibric acids in the management of hyperlipidemia
  Current Opinion in Lipidology, 1990
• Fibric acids: Effects on lipids and lipoprotein metabolism
  The American Journal of Medicine, 1987
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Mechanism of action of gemfibrozil on lipoprotein metabolism.
  Journal of Clinical Investigation, 1985
• Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man
  JAMA, 1984